Status:

COMPLETED

Diminish Chemotherapy Related Side Effects Through Patient Education

Lead Sponsor:

Milton S. Hershey Medical Center

Conditions:

Chemotherapeutic Toxicity

Chemotherapeutic Agent Toxicity

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Currently, there is a lack of patient education materials regarding cytotoxic chemotherapy side effects, research supported treatments, and the utilization of CAM by cancer patients at Penn State Canc...

Detailed Description

The diagnosis of cancer is a life-altering event which can cause a large amount of distress in patients. One of the several factors that impacts a patient's level of distress, is their fear of the dia...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Adults with a diagnosis of breast or gastrointestinal cancer, at any stage or progression, who are cytotoxic chemotherapy treatment naïve and initiating treatment or have newly begun cytotoxic chemotherapy within the last 6 weeks. Patients receiving multiple therapy forms, such as immune or humoral, can be included if they are also receiving cytotoxic chemotherapy as a part of their regimen. All patients will receive the brochure, therefore, there will not be a control arm in this study.
  • Adult \>20 year of age
  • Ability to understand and read written English without any functional difficulty
  • ECOG performance status 0-3
  • May be involved with other cancer trials being offered at the Penn State Cancer Institute
  • Exclusion Criteria
  • Inability to give informed consent
  • Pregnant females
  • Inability to understand or read written English
  • Patients who have previously undergone cytotoxic chemotherapy at any point in their lifetime or began chemotherapy for their breast or gastrointestinal cancer greater than 6 weeks from the initiation of the study

Exclusion

    Key Trial Info

    Start Date :

    March 24 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 21 2023

    Estimated Enrollment :

    36 Patients enrolled

    Trial Details

    Trial ID

    NCT04694794

    Start Date

    March 24 2021

    End Date

    August 21 2023

    Last Update

    September 1 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Penn State Cancer Institute

    Hershey, Pennsylvania, United States, 17033